Neuro-ophthalmology of movement disorders

Current Opinion in Ophthalmology

Volumn 23, Issue 6, 2012, Pages 491-496

  Clark, David ^a   Eggenberger, Eric ^a  

^a East Lansing   (United States)

Author keywords

Huntington disease; multisystem atrophy; Parkinson disease; progressive supranuclear palsy; Wilson disease

Indexed keywords

BENZATROPINE; BOTULINUM TOXIN A; CLONAZEPAM; DIAZEPAM; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; TRIHEXYPHENIDYL;

APRAXIA; BLEPHAROSPASM; BLINKING; CLINICAL FEATURE; DIPLOPIA; DRUG EFFICACY; DRY EYE; DYSLEXIA; ELECTROOCULOGRAPHY; EYE PAIN; EYELID RETRACTION; GAIT DISORDER; GAZE PARALYSIS; HEMIFACIAL SPASM; HUMAN; HUNTINGTON CHOREA; INTESTINE LIPODYSTROPHY; MAGNETIC RESONANCE ANGIOGRAPHY; MEIGE SYNDROME; MOTOR DYSFUNCTION; MULTISYSTEM ATROPHY; NEUROOPHTHALMOLOGY; NYSTAGMUS; PARKINSON DISEASE; PRIORITY JOURNAL; PRISM; PROGNOSIS; PROGRESSIVE SUPRANUCLEAR PALSY; QUALITY OF LIFE; REVIEW; SACCADIC EYE MOVEMENT; SEX RATIO; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SQUARE WAVE JERK; VESTIBULOOCULAR REFLEX; WILSON DISEASE;

DRY EYE SYNDROMES; EYE DISEASES; EYELID DISEASES; HUMANS; MOVEMENT DISORDERS; MULTIPLE SYSTEM ATROPHY; NYSTAGMUS, PATHOLOGIC; OCULAR MOTILITY DISORDERS; PARKINSON DISEASE; REFLEX, VESTIBULO-OCULAR; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84867886626     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0b013e328358ba14     Document Type: Review

References (38)

1. Peckham EL, Lopez G, Shamim EA, et al. Clinical features of patients with blepharospasm: a report of 240 patients. Eur J Neurol 2011; 18:382-386.
2. Miwa H, Kondo T, Mizuno Y. Bell's palsy-induced blepharospasm. J Neurol 2002; 249:452-454. (Pubitemid 34304621)
3. Skarf B. Normal and abnormal eyelid function. 6th ed. In: Miller NR, Newman NJ, editors. Walsh and Hoyt's Clinical Neuro-ophthalmology. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 1212.
4. Jankovic J, Orman J. Botulinum A toxin for cranial-cervical dystonia: a doubleblind, placebo-controlled study. Neurology 1987; 37:616-623. (Pubitemid 17057937)
5. Girlanda P, Quartarone A, Sinicropi S. Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study. Mov Disord 1996; 11:27-31. (Pubitemid 26008560)
6. Forget R, Tozlovanu V, Iancu A, Boghen D. Botulinum toxin improves lid opening delays in blepharospasm associated apraxia of eyelid opening. Neurology 2002; 58:1843-1846. (Pubitemid 34663589)
7. Tan EK, Chan LL, Lim SH, et al. Role of magnetic resonance imaging and magnetic resonance angiography in patients with hemifacial spasm. Ann Acad Med Singapore 1999; 28:169-173.
8. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56:33-39. (Pubitemid 29046907)
9. Lim SY, Lang AE. The nonmotor symptoms of Parkinson's disease-an overview. Mov Disord 2010; 25:S123-S130.
10. Almer Z, Klein KS, Marsh L, et al. Ocular motor and sensory function in Parkinson's disease. Ophthalmology 2012; 119:178-182.
11. Tomsak RL, Daroff RB. Ophthalmologic features of Parkinson's disease. Neurology 2004; 63:940.
12. Repka MX, Claro MC, Loupe DN, et al. Ocular motility in Parkinson's disease. J Pediatr Ophthalmol Strabismus 1996; 33:144-147. (Pubitemid 26000917)
13. Biousse V, Skiell BC, Watts RL, et al. Ophthalmologic features of Parkinson's disease. Neurology 2004; 62:177-180. (Pubitemid 38167121)
14. Golbe LI, Davis PH, Lepore FE. Eyelid movement abnormalities in progressive supranuclear palsy. Mov Disord 1989; 4:297-302. (Pubitemid 19270753)
15. Korosec M, Zidar I, Reits D, et al. Eyelid movements during blinking in patients with Parkinson's disease. Mov Disord 2006; 21:1248-1251. (Pubitemid 44336621)
16. Agostino R, Bologna M, Dinapoli L, et al. Voluntary, spontaneous, and reflex blinking in Parkinson's disease. Mov Disord 2008; 23:669-675.
17. Karson CN. Spontaneous eye-blink rates and dopaminergic systems. Brain 1983; 106:643-653. (Pubitemid 13051165)
18. Scheiman M, Gwiazda J, Li T. Surgical interventions for convergence insufficiency (review). The Cochrane Collaboration 2011:7-13.
19. Steele J, Richardson J, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving he brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964; 10:333-359.
20. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 1996; 47:1-9. (Pubitemid 26243849)
21. Friedman DI, Jankovic J, McCrary JA. Neuro-ophthalmic findings in progressive supranuclear palsy. J Clin Neuroophthalmol 1992; 12:104-109.
22. Mastaglia FL, Grainger KM. Intranuclear ophthalmoplegia in progressive supranuclear palsy. J Neurol Sci 1975; 25:303-308.
23. Bologna M, Agostino R, Gregori B, et al. Voluntary, spontaneous and reflex blinking in patients with clinically probable progressive supranuclear palsy. Brain 2009; 132:502-510.
24. Altiparmak UE, Eggenberger E, Coleman A, Condon K. The ratio of square wave jerks rates to blink rates distinguishes progressive supranuclear palsy from Parkinson disease. J Neuroophthalmol 2006; 26:257-259. (Pubitemid 46066878)
25. Chen AL, Riley DE, King SA, et al. The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis. Front Neurol 2010; 1: 1-19.
26. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71:670-676.
27. Anderson T, Luxon L, Quinn N, et al. Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients. Mov disord 2008; 23:977-984.
28. Fischer MD, Synofzik M, Heidlauf R, et al. Retinal nerve fiber layer loss in multiple system atrophy. Mov disord 2011; 26:914-916.
29. Sturrock A, Leavitt BR. The clinical and genetic features of Huntington disease. J Geriatr Psychiatry Neurol 2010; 23:243-259.
30. Quinn N, Schrag A. Huntington's disease and other choreas. J Neurol 1998; 245:709-716. (Pubitemid 28468469)
31. Lasker AG, Zee DS, Hain TC, et al. Saccades in Huntington's disease: slow and dysmetria. Neurology 1988; 38:427-431. (Pubitemid 18083683)
32. Patel SS, Jankovic J, Hood AJ, et al. Reflexive and volitional saccades: biomarkers of Huntington disease severity and progression. J Neurol Sci 2012; 313:35-41.
33. Ingster-Moati I, Quoc EB, Pless M, et al. Ocular motility and Wilson's disease: a study of 34 patients. J Neurol Neurosurg Psychiatry 2007; 78:1199-1201. (Pubitemid 350057282)
34. Lesnaik M, Czionkowska A, Seniow J. Abnormal antisaccades and smooth pursuit eye movements in patients with Wilson's disease. Mov Disord 2008; 23:2067-2073.
35. Whipple GH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Johns Hopkins Hosp Bull 1907; 18:382-391.
36. Raoult D, Birg ML, Scola BL, et al. Cultivation of the bacillus of Whipple's disease. N Engl J Med 2000; 342:620-625. (Pubitemid 30118414)
37. Durand DV, Lecomte C, Cathebras P, et al. Whipple disease: clinical review of 52 cases. Medicine 1997; 76:170-184. (Pubitemid 27255820)
38. Fenollar F, Puechal X, Roalt D. Whipple's disease. N Engl J Med 2007; 356:55-66. (Pubitemid 46041754)